Tests for Pancreatic Status
For evaluating pancreatic structure and function, start with fecal elastase-1 (FE-1) testing on semi-solid or solid stool as your initial functional test, and use cross-sectional imaging (CT, MRI, or endoscopic ultrasound) to assess pancreatic structure and underlying disease 1.
Functional Testing: Assessing Exocrine Pancreatic Function
First-Line Test: Fecal Elastase-1
- FE-1 is the most appropriate initial test for suspected exocrine pancreatic insufficiency (EPI) 1
- Must be performed on semi-solid or solid stool specimens (not liquid stool, which gives false positives)
- Interpretation:
- FE-1 <100 μg/g stool = good evidence of EPI
- FE-1 100-200 μg/g = indeterminate for EPI
- FE-1 ≥200 μg/g = normal pancreatic function 1
- Can be performed while patient is on pancreatic enzyme replacement therapy (PERT) 1
- Simple, noninvasive, and relatively inexpensive 1
Important caveat: FE-1 has limitations in moderate disease and can be falsely low in diarrheal states. The test measures elastase 3A and 3B (not elastase-1, despite the name) 1.
Alternative Functional Tests
Direct Pancreatic Function Tests:
- Most accurate but invasive, time-consuming, and available only at specialized centers 1
- Include endoscopic secretin-stimulated tests with aspiration of pancreatic secretions
- Measure bicarbonate concentration and pancreatic enzymes over 30-60 minutes 1
- Primarily used for diagnosing early-stage chronic pancreatitis rather than routine EPI diagnosis 2, 3
Serum Pancreatic Enzymes:
- Serum trypsin can be measured as an indirect test
- Not affected by PERT use
- Unreliable if patient has ongoing pancreatic inflammation 1
Fecal Fat Testing:
- Rarely needed in clinical practice 1
- Requires high-fat diet and 72-hour stool collection
- Quantitative testing is impractical for routine use 1
- Steatorrhea defined as coefficient of fat absorption <93% (>7% of ingested fat in stool) 1
Structural/Morphological Testing: Imaging the Pancreas
Cross-Sectional Imaging
These modalities diagnose underlying pancreatic disease but cannot directly identify EPI 1:
CT Scan:
- Multislice CT with precise protocol: arterial phase (25-40s) and portal phase (60s) after contrast
- Shows pancreatic atrophy, calcifications, ductal changes, masses
- Effective radiation dose: 8-12 mSv 4
MRI/MRCP:
- Standard MRI shows decreased T1 signal and glandular atrophy in chronic pancreatitis
- MRCP visualizes ductal system without radiation 5
- Secretin-stimulated MRCP evaluates side branch pathology and exocrine function dynamically 5
- Diffusion-weighted imaging can quantify parenchymal fibrosis 5
Endoscopic Ultrasound (EUS):
- Excellent for detecting early pancreatic changes
- Can be combined with endoscopic pancreatic function testing 6, 2
- Important limitation: EPI diagnosis shows poor correlation with EUS diagnosis of minimal-change chronic pancreatitis (sensitivity only 23.4%) 6
Clinical Algorithm for Testing
When to suspect pancreatic disease:
High-risk conditions (test these patients):
- Chronic pancreatitis
- Recurrent acute pancreatitis
- Pancreatic cancer
- Cystic fibrosis
- Previous pancreatic surgery 1
Moderate-risk conditions (consider testing):
- Duodenal diseases (celiac, Crohn's)
- Long-standing diabetes mellitus
- Previous intestinal surgery
- Hypersecretory states (Zollinger-Ellison syndrome) 1
Clinical presentation suggesting EPI:
- Steatorrhea with or without diarrhea
- Weight loss and bloating
- Fat-soluble vitamin deficiencies
- Protein-calorie malnutrition 1
Testing sequence:
- Order FE-1 test in appropriate clinical context with signs of maldigestion 1
- Obtain cross-sectional imaging (CT/MRI/EUS) to diagnose underlying pancreatic disease 1
- Reserve direct pancreatic function tests for specialized centers when diagnosis remains unclear 1
Common pitfall: Do not rely on therapeutic trial of pancreatic enzymes for diagnosis—this is unreliable 1. Make the diagnosis first with objective testing.